<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><strong><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">Selected Publications:</span></span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• </span></span><span style="color: #212121; font-family: 'system-ui', -apple-system, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Fira Sans', 'Droid Sans', 'Helvetica Neue', sans-serif; font-size: 16px;"><strong>Aleksic S,</strong> Desai D, Ye K, Duran S, Gao T, Crandall J, Atzmon G, Barzilai N, Milman S. Integrity of hypothalamic-pituitary-testicular axis in exceptional longevity. Aging Cell. 2022 Jun 29:e13656. doi: 10.1111/acel.13656. Epub ahead of print. PMID: 35770332.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• </span></span><span style="font-size: 11.0pt; font-family: 'Arial',sans-serif;">Kulkarni AS*, <strong>Aleksic S</strong>*, Berger DM, Sierra F, Kuchel GA, Barzilai N. Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization. Aging Cell. 2022 Apr;21(4):e13596. doi: 10.1111/acel.13596. Epub 2022 Mar 27. PMID: 35343051; PMCID: PMC9009114 <strong><span style="color: #212121; background: white;">(*equally contributed)</span></strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• </span></span><span style="font-family: Calibri, sans-serif; font-size: 16px;">Lontchi-Yimagou E*, </span><strong style="font-family: Calibri, sans-serif; font-size: 16px;">Aleksic S*,</strong><span style="font-family: Calibri, sans-serif; font-size: 16px;"> Hulkower R, et al. Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure. </span><em style="font-family: Calibri, sans-serif; font-size: 16px;">J Clin Endocrinol Metab</em><span style="font-family: Calibri, sans-serif; font-size: 16px;">. 2020;105(11):dgaa539. PMID: 32915987. </span><span style="font-size: 11.0pt; font-family: 'Arial',sans-serif;"><strong><span style="color: #212121; background: white;">(*equally contributed)</span></strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• <strong>Aleksic S</strong>, Eisenberg R, Tsomos E, et al. Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and</span></span> posttransplantation<span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"> diabetes: A single-center retrospective study. Diabetes Res Clin Pract. 2020 Jul;165:108221. PMCID: PMC7415727.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"> </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• Carey M, Lontchi-Yimagou E, Mitchell W, Reda S, Zhang K, Kehlenbrink S, Koppaka S, Maginley SR, <strong>Aleksic S</strong>, Bhansali S, Huffman DM, Hawkins M. Central KATP Channels Modulate Glucose Effectiveness in Humans and Rodents. Diabetes. 2020 Jun;69(6):1140-1148. PMCID: PMC7243288.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"> </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• Zhang WB*, <strong>Aleksic S*</strong>, Gao T, et al. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults. Cells. 2020 Jun 1;9(6). PMCID: PMC7349399. </span></span><span style="font-size: 11.0pt; font-family: 'Arial',sans-serif;"><strong><span style="color: #212121; background: white;">(*equally contributed)</span></strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"> </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• Jotic A, Milicic T, Covickovic Sternic N, Kostic VS, Lalic K, Jeremic V, Mijailovic M, Lukic L, Rajkovic N, Civcic M, Macesic M, Seferovic JP, Stanarcic J, <strong>Aleksic S</strong>, Lalic NM. Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke. Int J Endocrinol. 2015;2015:934791. PMCID: PMC4452095.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• Milicic T, Jotic A, Markovic I, Lalic K, Jeremic V, Lukic L, Rajkovic N, Popadic D, Macesic M, Seferovic JP, <strong>Aleksic S</strong>, Stanarcic J, Civcic M, Lalic NM. High Risk First Degree Relatives of Type 1 Diabetics: An Association with Increases in CXCR3(+) T Memory Cells Reflecting an Enhanced Activity of Th1 Autoimmune Response. Int J Endocrinol. 2014;2014:589360. PMCID: PMC3979071.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"> </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;">• Jotic A, Covickovic Sternic N, Kostic VS, Lalic K, Milicic T, Mijailovic M, Lukic Lj, Civcic M, Colak E, Macesic M, Seferovic JP, <strong>Aleksic S</strong>, Lalic N. Type 2 Diabetic Patients with Ischemic Stroke: Decreased Insulin Sensitivity and Decreases in Antioxidant Enzyme Activity Are Related to Different Stroke Subtypes. Int J Endocrinol. 2013;2013:401609. PMCID: PMC3697295.</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; text-align: justify;"><span style="font-family: Calibri, sans-serif;"><span style="font-size: 16px;"> </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; text-align: justify;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Calibri, sans-serif; text-align: justify;"><span style="font-size: 12pt;"> </span></p>